グラタマタージックシナプスにおけるGABA (((B)) 受容体活性化によるシナプスベジクルプライミングの直接調節
1Department of Membrane Biophysics, Max Planck Institute for Biophysical Chemistry, Göttingen 37077, Germany.
Nature
|August 15, 2003
まとめ
Gタンパク質のシグナル伝達は,GABA (((B)) 受容体を通じたように,循環型AMP (cAMP) を減少させることで,シナプス膀の募集を遅らせます. これは,神経伝達物質の放出を調節することによって,神経ネットワークのダイナミクスに影響を与えます.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- セルラー・シグナリング
背景:
- Gタンパク質とカルシウムカスケードは,神経伝達物質の放出を調節する.
- 前シナプスカルシウムの流入は,放出を調節する重要なターゲットです.
研究 の 目的:
- シナプスの徴募におけるGタンパク質シグナル伝達の役割を調査する.
- GABA(B) 受容体の活性化がシナプス可塑性に影響するメカニズムを解明する.
主な方法:
- Gタンパク質媒介のシグナル伝達経路を研究した.
- GABA(B) 受容体の活性化がシナプス везикулの動態に及ぼす影響を調べました.
- 循環型AMP (cAMP) とカルシウムの膀原始化における役割を調査した.
主要な成果:
- GABA (B) 受容体経由のGタンパク質シグナル伝達は,持続的な活動と短期的なうつ病の間,シナプス膀の募集を遅らせます.
- この遅延は,cAMPの減少によって媒介され,これは,膀の募集に対するカルシウムの刺激効果を阻害する.
- cAMPとカルシウム/カルモジュリンは,膀のプライミングを強化するために協力します.
結論:
- Gタンパク質シグナリングは,シナプス前抑制とシナプス抑うつからのカルシウム依存回復を差異的に調節します.
- これらの発見は,ニューラルネットワークのダイナミクスとシナプス可塑性を理解するための意味を持つ.
さらに関連する動画
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
19.5K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.1K
関連する概念動画
01:26Fusion of Secretory Vesicles with the Plasma Membrane
15.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
15.9K
01:26Chemical Synapses
9.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
01:26Chemical Synapses
10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K